Titan Biotech Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹56.51 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.97 per cent from ₹54.35 crore. This corresponds to a year-on-year *(YoY) growth of 47.62 per cent.
Operating Profit
Operating Profit stands at ₹10.83 crore, reflecting a quarter-on-quarter *(QoQ) increase of 16.20 per cent from ₹9.32 crore. This corresponds to a year-on-year *(YoY) growth of 123.30 per cent.
PBDT
PBDT stands at ₹12.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.33 per cent from ₹11.33 crore. This corresponds to a year-on-year *(YoY) growth of 81.69 per cent.
Profit Before Tax
Profit Before Tax stands at ₹11.23 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.97 per cent from ₹10.12 crore. This corresponds to a year-on-year *(YoY) growth of 97.02 per cent.
Net Profit
Net Profit stands at ₹8.53 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.92 per cent from ₹7.76 crore. This represents a 94.31 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Titan Biotech Ltd Earnings
- YOY
- QOQ
Titan Biotech Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Titan Biotech Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Titan Biotech Ltd Financial Reports
Titan Biotech Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Titan Biotech | -5.00% | -18.45% | 11.31% | 108.76% | 73.33% | 326.47% |
| Panacea Biotec | 0.54% | 0.82% | -4.58% | -20.69% | -26.12% | -31.49% |
| Sai Parenteral's | -0.05% | 4.37% | 4.27% | 4.27% | 4.27% | 4.27% |
| Indoco Remedies | 0.82% | 6.39% | 1.28% | -5.98% | -31.67% | -13.20% |
| Solara Active | 1.82% | 3.96% | 9.01% | -11.14% | -17.91% | -5.67% |
| Windlas Biotech | -0.12% | 3.35% | 8.31% | 5.83% | -12.15% | -25.27% |
| Kwality Pharma | 3.06% | 8.38% | -6.45% | 41.81% | 80.06% | 89.69% |
Company Info
Company Information
Chairman & Independent Directo : Rohit Jain
ED / MD / Promoter : Naresh Kumar Singla
ED / MD / Promoter : Suresh Chand Singla
Non-Exec & Non-Independent Dir : Manju Singla
Non-Exec & Non-Independent Dir : Supriya Singla
Independent Non Exe. Director : Dhairya Madan
Independent Non Exe. Director : Brijesh Kumar Singh
Independent Non Exe. Director : Abhishek Agarwal
WTD & Executive Director : Raja Singla
E D & Wholetime Director : Udit Singla
E D & Wholetime Director : Shivom Singla
Independent Non Exe. Director : Debendra Kumar Sabat
Company Sec. & Compli. Officer : CHARANJIT SINGH